Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection · Sponsor: Merck Sharp & Dohme LLC
Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral therapy (ART), which includes taking medicines to lower the amount of HIV-1 in the body. Standard ART helps people live longer, but people must take up to 3 medicines up to twice a day. Standard ART may also cause other health problems. Researchers want to know if a study ART works as well as a standard ART to treat HIV-1. The study ART combines 2 medicines, islatravir and ulonivirine, and is taken once a week. The goals of this study are to learn: 1) If the study ART works as well as a standard ART to treat HIV-1, and 2) About the safety of the study ART and if people tolerate it compared to a standard ART.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Ruane Clinical Research Group, Inc. ( Site 1513) | Los Angeles, California, United States | Recruiting |
| Vivent Health ( Site 1519) | Denver, Colorado, United States | Recruiting |
| Whitman-Walker Institute ( Site 1538) | Washington D.C., District of Columbia, United States | Recruiting |
| Midway Immunology and Research Center ( Site 1503) | Ft. Pierce, Florida, United States | Recruiting |
| CAN Community Health- Miami Gardens ( Site 1549) | Miami Gardens, Florida, United States | Recruiting |
| Orlando Immunology Center ( Site 1501) | Orlando, Florida, United States | Recruiting |
| CAN Community Health ( Site 1510) | Sarasota, Florida, United States | Recruiting |
| Triple O Research Institute ( Site 1505) | West Palm Beach, Florida, United States | Recruiting |
| Metro Infectious Diseases Consultants L.L.C. ( Site 1509) | Decatur, Georgia, United States | Recruiting |
| Mercer university, Department of internal medicine-Clinical Research ( Site 1512) | Macon, Georgia, United States | Recruiting |
| Rush University Medical Center-Infectious Disease ( Site 1522) | Chicago, Illinois, United States | Recruiting |
| Henry Ford Hospital ( Site 1535) | Detroit, Michigan, United States | Recruiting |
+ 43 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07266831